Juan Pablo Arab

25.4k total citations · 6 hit papers
188 papers, 5.6k citations indexed

About

Juan Pablo Arab is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Juan Pablo Arab has authored 188 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Epidemiology, 84 papers in Hepatology and 75 papers in Pathology and Forensic Medicine. Recurrent topics in Juan Pablo Arab's work include Liver Disease Diagnosis and Treatment (144 papers), Alcohol Consumption and Health Effects (73 papers) and Liver Disease and Transplantation (62 papers). Juan Pablo Arab is often cited by papers focused on Liver Disease Diagnosis and Treatment (144 papers), Alcohol Consumption and Health Effects (73 papers) and Liver Disease and Transplantation (62 papers). Juan Pablo Arab collaborates with scholars based in Chile, United States and Canada. Juan Pablo Arab's co-authors include Marco Arrese, Michael Trauner, Vijay H. Shah, Patrick S. Kamath, Sumeet K. Asrani, Yvonne Ayerki Nartey, Elisa Pose, Harshad Devarbhavi, Ramón Bataller and Paul A. Dawson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Juan Pablo Arab

171 papers receiving 5.5k citations

Hit Papers

Global burden of liver di... 2016 2026 2019 2022 2023 2016 2018 2022 2023 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global burden of liver disease: 2023 update
    2023 987 citations Juan Pablo Arab et al. profile →
  2. Bile acids and nonalcoholic fatty liver disease
    2016 478 citations Juan Pablo Arab, Marco Arrese et al. profile →
  3. Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
    2018 422 citations Juan Pablo Arab, Marco Arrese et al. Annual Review of Pathology Mechanisms of Disease profile →
  4. Alcohol-Associated Hepatitis
    2022 117 citations Ramón Bataller, Juan Pablo Arab et al. New England Journal of Medicine profile →
  5. The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
    2023 99 citations Luis Antonio Díaz, Juan Pablo Arab et al. Nature Reviews Gastroenterology & Hepatology profile →
  6. Acute liver failure
    2024 42 citations Anand V. Kulkarni, Juan Pablo Arab et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan Pablo Arab Chile 37 3.8k 1.8k 1.2k 1.2k 1.0k 188 5.6k
Antonio Grieco Italy 38 3.9k 1.0× 2.1k 1.2× 764 0.6× 1.5k 1.3× 1.4k 1.3× 225 6.5k
Suthat Liangpunsakul United States 50 3.6k 0.9× 1.7k 0.9× 2.1k 1.7× 1.9k 1.6× 1.0k 1.0× 252 7.3k
Ajay Duseja India 38 4.8k 1.3× 3.6k 2.0× 610 0.5× 926 0.8× 1.1k 1.1× 328 6.4k
Nahúm Méndez‐Sánchez Mexico 43 4.2k 1.1× 2.4k 1.3× 604 0.5× 1.1k 1.0× 1.3k 1.2× 302 7.8k
Marcello Persico Italy 41 4.3k 1.1× 3.3k 1.8× 540 0.4× 716 0.6× 987 0.9× 204 6.5k
Bilal Hameed United States 24 4.1k 1.1× 2.5k 1.4× 432 0.3× 857 0.7× 1.3k 1.2× 70 5.7k
Dae Won Jun South Korea 37 3.1k 0.8× 1.5k 0.8× 514 0.4× 1.0k 0.9× 1.1k 1.0× 290 5.3k
Ashwani K. Singal United States 47 4.8k 1.3× 3.5k 2.0× 2.5k 2.1× 944 0.8× 901 0.9× 226 7.2k
Jörn M. Schattenberg Germany 50 6.7k 1.8× 3.4k 1.9× 953 0.8× 1.6k 1.4× 2.5k 2.4× 332 9.2k
Mariana Verdelho Machado Portugal 36 4.9k 1.3× 1.8k 1.0× 644 0.5× 2.1k 1.8× 1.9k 1.8× 90 6.7k

Countries citing papers authored by Juan Pablo Arab

Since Specialization
Citations

This map shows the geographic impact of Juan Pablo Arab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Pablo Arab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Pablo Arab more than expected).

Fields of papers citing papers by Juan Pablo Arab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Pablo Arab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Pablo Arab. The network helps show where Juan Pablo Arab may publish in the future.

Co-authorship network of co-authors of Juan Pablo Arab

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Pablo Arab. A scholar is included among the top collaborators of Juan Pablo Arab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Pablo Arab. Juan Pablo Arab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huidobro, Andrea, Danilo Alvares, Francisco Cruz‐Quintana, et al.. (2025). New steatotic liver disease criteria diagnostic performance in an agricultural population in Chile. Annals of Hepatology. 30(2). 101919–101919.
2.
Mujoomdar, Amol, Derek W. Cool, Anouar Teriaky, et al.. (2025). Effectiveness of retrograde transvenous obliteration for primary prophylaxis of gastric variceal bleeding. PubMed. 8(1). 79–89.
3.
Díaz, Luis Antonio, et al.. (2025). Public Health Policies and Strategies to Prevent Alcohol-Related Morbidity and Mortality. Current Hepatology Reports. 24(1).
4.
Kulkarni, Anand V., Karan Kumar, Somaya Albhaisi, et al.. (2024). Impact of Karnofsky performance status on outcomes of patients with severe alcohol‐associated hepatitis: a propensity‐matched analysis. Internal Medicine Journal. 55(1). 109–116. 1 indexed citations
5.
Díaz, Luis Antonio, Antonio Gil‐Gómez, Jeremy P. Burton, et al.. (2024). Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology. 31(Suppl). S94–S111. 26 indexed citations
6.
Dunn, Winston, Naim Alkhouri, Terry Cheuk‐Fung Yip, et al.. (2024). Su1537 MACHINE LEARNING ADVANCED FIBROSIS AND AT-RISK MASH (ALADDIN) WITH A WEB-BASED CALCULATOR FOR PROBABILITY PREDICTION. Gastroenterology. 166(5). S–1629. 2 indexed citations
7.
Danpanichkul, Pojsakorn, Cheng Han Ng, Mark Muthiah, et al.. (2023). From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women. The American Journal of Gastroenterology. 119(5). 893–909. 22 indexed citations
8.
Allen, Alina M., Zobair M. Younossi, Emmanuel Tsochatzis, et al.. (2023). Measuring NAFLD models of care. Nature Reviews Gastroenterology & Hepatology. 20(10). 626–627. 7 indexed citations
9.
Kulkarni, Anand V., Karan Kumar, & Juan Pablo Arab. (2023). Role of Prophylactic Antibiotics in Patients with Severe Alcohol-related Hepatitis. Journal of Clinical and Experimental Hepatology. 13(6). 1146–1148. 2 indexed citations
10.
Sedaño, Rocío, Daniel Cabrera, Christopher Ma, et al.. (2022). Immunotherapy for Cancer: Common Gastrointestinal, Liver, and Pancreatic Side Effects and Their Management. The American Journal of Gastroenterology. 117(12). 1917–1932. 11 indexed citations
11.
Bataller, Ramón, Juan Pablo Arab, & Vijay H. Shah. (2022). Alcohol-Associated Hepatitis. New England Journal of Medicine. 387(26). 2436–2448. 117 indexed citations breakdown →
12.
Arnold, Jorge, Luis Antonio Díaz, Francisco Idalsoaga, et al.. (2022). Alcohol Consumption: Medical Implications, the Liver and Beyond. Alcohol and Alcoholism. 57(3). 283–291. 60 indexed citations
13.
Díaz, Luis Antonio, Gustavo Ayares, Jorge Arnold, et al.. (2022). Liver Diseases in Latin America: Current Status, Unmet Needs, and Opportunities for Improvement. Current Treatment Options in Gastroenterology. 20(3). 261–278. 19 indexed citations
14.
Lonardo, Amedeo, Juan Pablo Arab, & Marco Arrese. (2021). Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management. Advances in Therapy. 38(5). 2130–2158. 63 indexed citations
15.
Kulkarni, Anand V., Harsh Vardhan Tevethia, Juan Pablo Arab, et al.. (2021). Efficacy and safety of obeticholic acid in liver disease—A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 45(3). 101675–101675. 30 indexed citations
16.
Díaz, Luis Antonio, Francisco Fuster García, Alejandro Soza, et al.. (2020). Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high‐risk gastro‐oesophageal varices in a Chilean cohort. Liver International. 40(6). 1427–1434. 14 indexed citations
17.
Arab, Juan Pablo, Marco Arrese, & Michael Trauner. (2018). Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease. Annual Review of Pathology Mechanisms of Disease. 13(1). 321–350. 422 indexed citations breakdown →
18.
Cabrera, Daniel, Claudio Cabello‐Verrugio, Nancy Solı́s, et al.. (2018). Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation. International Journal of Molecular Sciences. 19(5). 1339–1339. 23 indexed citations
19.
Arab, Juan Pablo, Juan Carlos Claro, Juan Pablo Arancibia, et al.. (2016). Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus. World Journal of Hepatology. 8(25). 1075–1075. 9 indexed citations
20.
Sotelo, Julio, Juan Pablo Arab, Marco Arrese, et al.. (2015). Intrahepatic portal vein blood volume estimated by non-contrast magnetic resonance imaging for the assessment of portal hypertension. Magnetic Resonance Imaging. 33(8). 970–977. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Grieco Breakdown of academic impact, for papers by Suthat Liangpunsakul Breakdown of academic impact, for papers by Ajay Duseja Breakdown of academic impact, for papers by Nahúm Méndez‐Sánchez Breakdown of academic impact, for papers by Marcello Persico Breakdown of academic impact, for papers by Bilal Hameed Breakdown of academic impact, for papers by Dae Won Jun Breakdown of academic impact, for papers by Ashwani K. Singal Breakdown of academic impact, for papers by Jörn M. Schattenberg Breakdown of academic impact, for papers by Mariana Verdelho Machado
Rankless by CCL
2026